Assembly Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASMB and other ETFs, options, and stocks.About ASMB
Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes.
CEOJason A. Okazaki
CEOJason A. Okazaki
Employees73
Employees73
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2005
Founded2005
Employees73
Employees73
ASMB Key Statistics
Market cap528.93M
Market cap528.93M
Price-Earnings ratio-6.94
Price-Earnings ratio-6.94
Dividend yield—
Dividend yield—
Average volume182.92K
Average volume182.92K
High today$33.96
High today$33.96
Low today$32.67
Low today$32.67
Open price$33.33
Open price$33.33
Volume113.80K
Volume113.80K
52 Week high$39.71
52 Week high$39.71
52 Week low$7.75
52 Week low$7.75
Stock Snapshot
With a market cap of 528.93M, Assembly Biosciences(ASMB) trades at $33.32. The stock has a price-to-earnings ratio of -6.94.
On 2025-12-30, Assembly Biosciences(ASMB) stock moved within a range of $32.67 to $33.96. With shares now at $33.32, the stock is trading +2.0% above its intraday low and -1.9% below the session's peak.
Trading activity shows a volume of 113.8K, compared to an average daily volume of 182.92K.
The stock's 52-week range extends from a low of $7.75 to a high of $39.71.
The stock's 52-week range extends from a low of $7.75 to a high of $39.71.
People also own
Based on the portfolios of people who own ASMB. This list is generated using Robinhood data, and it’s not a recommendation.